Portfolio Companies News
August 3, 2021SynOx Therapeutics Further Strength...
Seasoned team to drive forward pivotal trial for patients suffering from Tenosynovial Giant Cell Tumours (TGCT)Follows recent appointments of Professor Ton Logtenberg as non-executive Chairman and Ray Barlow as Chief Executive Officer Dublin, Ireland, August 3, 2021: SynOx Therapeutics Limi... read more
July 28, 2021Fusion Pharmaceuticals Announces FD...
HAMILTON, ON and BOSTON, July 28, 2021 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the U.S. Food and Drug Administration... read more
July 28, 2021Regulatory update from US Food and ...
July 28, 2021Regulatory STOCKHOLM — July 28, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the US Food and Drug Administration, FDA, has issued a saf... read more
July 27, 2021Pulmonx Announces Long-Term Follow-...
Newly Published Data Shows Positive, Durable Benefits of the Only Minimally Invasive Treatment Approved for Patients with Homogeneous Emphysema, a Form of Severe COPD with Widespread Destruction of Lung Tissue REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jul. 27, 2021-- Pulmonx Corporat... read more
July 27, 2021SynOx Therapeutics Strengthens Team...
Plans to initiate a pivotal trial for patients suffering from Tenosynovial Giant Cell Tumours (TGCT)Follows €37 M Series A investment to progress emactuzumab, a potentially best-in-class CSF-1R antibody licensed on an exclusive, worldwide basis from Roche Dublin, Ireland, July 27, 2021:&n... read more
July 22, 2021Q2 2021 General Market Overview
Since the start in 1996, HealthCap funds have invested in 121 portfolio companies.
46 of the portfolio companies have been taken public on nine different markets.
27 of the portfolio companies pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 12 companies with a valuation of USD 1 billion or more.